Cross Country Healthcare (NASDAQ: CCRN) reported Q3 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $315.12 million versus the consensus estimate of $310.22 million.

GUIDANCE:

Cross Country Healthcare sees Q4 2024 EPS of $0.10-$0.14, versus the consensus of $0.13. Cross Country Healthcare sees Q4 2024 revenue of $300-310 million, versus the consensus of $319 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.